Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
Mayte Suárez‐Fariñas, Benjamin Ungar, Shinji Noda, et al.
Journal of Allergy and Clinical Immunology (2015) Vol. 136, Iss. 5, pp. 1277-1287
Closed Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases
Mübeccel Akdiş, Alar Aab, Can Altunbulakli, et al.
Journal of Allergy and Clinical Immunology (2016) Vol. 138, Iss. 4, pp. 984-1010
Open Access | Times Cited: 750
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman‐Yassky, Robert Bissonnette, Benjamin Ungar, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 143, Iss. 1, pp. 155-172
Open Access | Times Cited: 543
Microbe-host interplay in atopic dermatitis and psoriasis
Nanna Fyhrquist, Gareth Muirhead, Stefanie Prast‐Nielsen, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 301
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis
Emma Guttman‐Yassky, Andrew Blauvelt, Lawrence F. Eichenfield, et al.
JAMA Dermatology (2020) Vol. 156, Iss. 4, pp. 411-411
Open Access | Times Cited: 278
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
Anniina Virtanen, T. Haikarainen, Juuli Raivola, et al.
BioDrugs (2019) Vol. 33, Iss. 1, pp. 15-32
Open Access | Times Cited: 244
Early-onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22-centered inflammation and lipid alterations
Patrick M. Brunner, Ariel Israel, Ning Zhang, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 141, Iss. 6, pp. 2094-2106
Open Access | Times Cited: 218
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
Cheng Zhou, Xiangqian Li, Chen Wang, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 61, Iss. 3, pp. 403-423
Closed Access | Times Cited: 218
Efficacy and safety of ustekinumab treatment in adults with moderate‐to‐severe atopic dermatitis
Saakshi Khattri, Patrick M. Brunner, Sandra Garcet, et al.
Experimental Dermatology (2016) Vol. 26, Iss. 1, pp. 28-35
Open Access | Times Cited: 202
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab
Patrick M. Brunner, Ana B. Pavel, Saakshi Khattri, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 143, Iss. 1, pp. 142-154
Open Access | Times Cited: 166
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
Ann Sterkens, Jacques Lambert, Bervoets An
Clinical and Experimental Medicine (2021) Vol. 21, Iss. 2, pp. 215-230
Closed Access | Times Cited: 116
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults
Yael Renert‐Yuval, Ester Del Duca, Ana B. Pavel, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 1, pp. 148-163
Open Access | Times Cited: 115
Familial aggregation of alopecia areata
Bettina Blaumeiser, Ineke van der Goot, Rolf Fimmers, et al.
Journal of the American Academy of Dermatology (2006) Vol. 54, Iss. 4, pp. 627-632
Closed Access | Times Cited: 297
Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches
Matthew Moyle, Ferda Cevikbas, Jamie L. Harden, et al.
Experimental Dermatology (2019) Vol. 28, Iss. 7, pp. 756-768
Open Access | Times Cited: 140
New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines
Yael Renert‐Yuval, Emma Guttman‐Yassky
Annals of Allergy Asthma & Immunology (2019) Vol. 124, Iss. 1, pp. 28-35
Closed Access | Times Cited: 117
Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation
Hui Li, Qi Yao, Alberto Garcia Mariscal, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 116
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
Ana B. Pavel, Teresa Song, Hyun Je Kim, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 144, Iss. 4, pp. 1011-1024
Open Access | Times Cited: 110
Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial
Robert Bissonnette, Ana B. Pavel, Aisleen Diaz, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 144, Iss. 5, pp. 1274-1289
Open Access | Times Cited: 106
Understanding autoimmunity of vitiligo and alopecia areata
Jillian F. Rork, Mehdi Rashighi, John E. Harris
Current Opinion in Pediatrics (2016) Vol. 28, Iss. 4, pp. 463-469
Open Access | Times Cited: 101
Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients
Emma Guttman‐Yassky, Yael Renert‐Yuval, Jennifer Bares, et al.
Allergy (2021) Vol. 77, Iss. 3, pp. 897-906
Open Access | Times Cited: 97
The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
Yael Renert‐Yuval, Emma Guttman‐Yassky
Advances in Therapy (2017) Vol. 34, Iss. 7, pp. 1594-1609
Open Access | Times Cited: 94
Human αβ and γδ T Cells in Skin Immunity and Disease
Michelle S. Cruz, Alani Diamond, Astrid Russell, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 94
Molecular signatures define alopecia areata subtypes and transcriptional biomarkers
Ali Jabbari, Jane Cerise, James C. Chen, et al.
EBioMedicine (2016) Vol. 7, pp. 240-247
Open Access | Times Cited: 91
Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines
M. Fukuyama, Taisuke Ito, Manabu Ohyama
The Journal of Dermatology (2021) Vol. 49, Iss. 1, pp. 19-36
Closed Access | Times Cited: 90
The many faces of interleukin-17 in inflammatory skin diseases
Reinhart Speeckaert, Jo Lambert, Lynda Grine, et al.
British Journal of Dermatology (2016) Vol. 175, Iss. 5, pp. 892-901
Closed Access | Times Cited: 87
Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
Kym A. Bain, Elizabeth S. McDonald, Fiona Moffat, et al.
British Journal of Dermatology (2019)
Open Access | Times Cited: 81
Page 1 - Next Page

Scroll to top